Wednesday, August 15, 2018 7:52:22 AM
This contract expands the outreach for PAS and the CIIT Center to treat Medicare based patients at six specific facilities bringing the patient cutting edge therapies that are currently instituted at the CIIT Center. Through Medicare billing of these therapies, the CIIT Center estimates over $1,500,000 in additional revenue annually.
Recognizing this potential, much of our work in 2018 focused on building a strong operational foundation to capitalize on the rapidly-evolving healthcare market of treating these adults who suffer these types of chronic illnesses, and the therapies that we can bring to them.
Our management team remains dedicated to creating value for our shareholders. We will continue to demonstrate our commitment to the future of PASO through positive steps at improving our capital structure, increasing revenues, and strengthening our internal controls to monitor our costs.
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM